Advertisement
Screener

BIOLASE, INC. Cash and securities

BIOLASE, INC. Cash and securities

  • Total cash · latest quarter (USD): Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities. Period ending 2024-09-30..
  • Cash per share · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2024-09-30..

Cash and securities

Overview →

Financial period ending 2024-09-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
Total cash · latest quarter (USD)(m)Cash and cash equivalents plus current marketable securities. Period ending 2024-09-30.

Calculation unavailable: missing inputs remain (m).

Cash per share · latest quarter(m)Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2024-09-30.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Cash and equivalents3.44M USDCash and Cash Equivalents, at Carrying Value
Short-term securities(m)
Cash and current securities(m)Cash and Cash Equivalents, at Carrying Value
Quarter-end shares(m)Common Stock, Shares, Outstanding

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingTotal cashCash per shareCash and equivalents (USD)Short-term securities (USD)Quarter-end shares (shares)
2024-09-30(m)(m)$3.44M(m)(m)
2024-06-30(m)(m)$5.27M(m)(m)
2024-03-31(m)(m)$6.39M(m)(m)
2023-12-31(m)(m)$6.57M(m)(m)
2023-09-30(m)(m)$7.81M(m)(m)
2023-06-30(m)(m)$6.93M(m)(m)
2023-03-31(m)(m)$6.53M(m)(m)
2022-12-31(m)(m)$4.18M(m)(m)
2022-09-30(m)(m)$9.96M(m)(m)
2022-06-30(m)(m)$19.55M(m)(m)
2022-03-31(m)(m)$21.61M(m)(m)
2021-12-31(m)(m)$29.97M(m)(m)
2021-09-30(m)(m)$33.38M(m)(m)
2021-06-30(m)(m)$37.08M(m)(m)
2021-03-31(m)(m)$40.84M(m)(m)
2020-12-31(m)(m)$17.56M(m)(m)
2020-09-30(m)(m)$18.85M(m)(m)
2020-06-30(m)(m)$5.44M(m)(m)
2020-03-31(m)(m)$1.51M(m)(m)
2019-12-31(m)(m)$5.79M(m)(m)
2019-09-30(m)(m)$2.09M(m)(m)
2019-06-30(m)(m)$3.72M(m)(m)
2019-03-31(m)(m)$2.96M(m)(m)
2018-12-31(m)(m)$8.04M(m)(m)
2018-09-30(m)(m)$2.24M(m)(m)
2018-06-30(m)(m)$2.90M(m)(m)
2018-03-31(m)(m)$8.48M(m)(m)
2017-12-31(m)(m)$11.64M(m)(m)
2017-09-30(m)(m)$4.45M(m)(m)
2017-06-30(m)(m)$7.92M(m)(m)
2017-03-31(m)(m)$3.58M(m)(m)
2016-12-31(m)(m)$8.92M(m)(m)
2016-09-30(m)(m)$12.65M(m)(m)
2016-06-30(m)(m)$4.88M(m)(m)
2016-03-31(m)(m)$6.63M(m)(m)
2015-12-31(m)(m)$11.70M(m)(m)
2015-09-30(m)(m)$15.19M(m)(m)
2015-06-30(m)(m)$19.92M(m)(m)
2015-03-31(m)(m)$23.74M(m)(m)
2014-12-31(m)(m)$31.56M(m)(m)
2014-09-30(m)(m)$2.76M(m)(m)
2014-06-30(m)(m)$2.08M(m)(m)
2014-03-31(m)(m)$1.83M(m)(m)
2013-12-31(m)(m)$1.44M(m)(m)
2013-09-30(m)(m)$4.15M(m)(m)
2013-06-30(m)(m)$2.10M(m)(m)
2013-03-31(m)(m)$1.23M(m)(m)
2012-12-31(m)(m)$2.54M(m)(m)
2012-09-30(m)(m)$1.29M(m)(m)
2012-06-30(m)(m)$1.61M(m)(m)
2012-03-31(m)(m)$2.77M(m)(m)
2011-12-31(m)(m)$3.31M(m)(m)
2011-09-30(m)(m)$5.76M(m)(m)
2011-06-30(m)(m)$10.13M(m)(m)
2011-03-31(m)(m)$1.63M(m)(m)
2010-12-31(m)(m)$1.69M(m)(m)
2010-09-30(m)(m)$2.23M(m)(m)
2010-06-30(m)(m)$2.90M(m)(m)
2009-12-31(m)(m)$2.98M(m)(m)
2008-12-31(m)(m)$11.23M(m)(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.